Development of an Innovative Point-of-Care Screening Tool for Alzheimer's Disease

开发一种创新的阿尔茨海默病即时护理筛查工具

• 批准号: 569580-2021
• 负责人: Méthot, Nathalie
• 金额: $ 2.19万
• 依托单位: La Cité collégiale
• 依托单位国家: 加拿大
• 项目类别: Applied Research and Development Grants - Level 1
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-01-01 至 2022-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=724296
• 关键词: Development; Innovative; Point; Care; Screening

Recherches Neuro-Hippocampe Inc. is a private clinical research institution comprised of physicians and researchers studying Alzheimer's disease for the past 20 years. They are currently conducting Phase 2b and Phase 3 clinical trials at their Ottawa and Gatineau sites. It has been shown that early detection of Alzheimer's disease allows for improved efficacy of therapeutic interventions and quality of life. Therefore, as part of their preclinical program, and in collaboration with two research centers at La Cité, RNH aims to develop a point-of-care diagnostic tool to non-invasively detect risk genes associated with Alzheimer's disease in the younger at-risk population. The Centre for Expertise in Smart Prototyping, and the Technology Access Centre of Bio-Innovation, at La Cité have the expertise in personnel and specialized equipment to help RNH in their endeavor.

Recherches Neuro-Hampocampe Inc.是一家私人临床研究机构，该机构完成了过去20年来研究阿尔茨海默氏病的医师和研究人员。他们目前正在其渥太华和加蒂诺站进行2B期和3期临床试验。已经表明，早期发现阿尔茨海默氏病可以提高治疗干预效率和生活质量。因此，作为其临床前计划的一部分，并与LaCité的两个研究中心合作，RNH旨在开发一种保健点诊断工具，以在年轻的高危人群中非侵入性检测与阿尔茨海默氏病有关的风险基因。 LaCité的Smart原型制作专业知识中心和生物创新技术中心具有亲自和专业设备的专业知识，可以帮助RNH努力。